Breast Cancer Case Discussions – Dylan Zylla, MD & Mark Menge, MD
HealthPartners is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
HealthPartners Office of Continuing Medical Education designates this live activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
- 0.50 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program
- 0.50 MOC Lifelong Learning point in the American Board of Pathology (ABPath) Continuing Certification program
- Credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM, ABPath MOC or ABS credit.
Regularly attending this series will allow participants to be able to:
- Apply advances in diagnostic evaluation of breast abnormalities and malignancies
- Implement advances in appropriate surgical intervention for various breast cancer malignancies and patient situations
- Assess the role of radiation therapy, chemotherapy, hormonal therapy, research and genetic testing in providing optimal care for patients with breast cancer
- 0.50 AMA PRA Category 1 Credit™
- 0.50 AttendanceThis program is designed to meet the Minnesota Board of Nursing’s requirements. It is the responsibility of each nurse to determine if the program meets the criteria for licensure or recertification in their discipline.